The anti-inflammatory and anti-glycative effects of rosmarinic acid in the livers of type 1 diabetic mice
Authors:
Open Access
- 25 August 2017
- journal article
- Published by China Medical University in BioMedicine
- Vol. 7 (3) , 19
Abstract
Rosmarinic acid (RA) is a polyphenol present in members of the Lamiaceae family. In this study, yhe anti-inflammatory and anti-glycative effects of RA in the livers of type 1 diabetic mice were examined. The diabetic mice were divided into three groups: diabetic mice with 0, low dose RA (25 mg/ml), and high dose RA (50 mg/ml). One group of non-diabetic mice was used as a control for comparison. RA was supplied via daily 200 μL oral injections for 9 weeks. The level of interleukin (IL)-6, the tumor necrosis factor (TNF)-alpha, the prostaglandin E2 (PGE2), and the activity of cyclooxygenase (COX)-2 in the livers were measured. The hepatic receptor of advanced glycative endproduct (RAGE), the sorbitol levels, and the glyoxalase 1 (GLO-1) activity were also determined. Compared with diabetic group that received no RA, the groups with RA supplements at both levels of dosages had increased body weight and had both decreased water intake and feed intake (p < 0.05). RA intake was found to reduce plasma glucose level and elevate plasma insulin level when compared with the diabetic group that received no RA (p < 0.05). RA treatments lowered the hepatic level of IL-6, TNF-alpha, and PGE2, as well as the activity of COX-2 (p < 0.05). RA administration also decreased hepatic RAGE and sorbitol levels, and GLO-1 activity when compared with the diabetic group that received no RA (P < 0.05). These findings support the conclusion that rosmarinic acid (RA) could be a potent protective agent for the liver against diabetic injury.Keywords
This publication has 23 references indexed in Scilit:
- Glycative Stress and Its Defense Machinery Glyoxalase 1 in Renal PathogenesisInternational Journal of Molecular Sciences, 2017
- Receptor for Advanced Glycation End Products (RAGE) in Type 1 Diabetes PathogenesisCurrent Diabetes Reports, 2016
- Rosmarinic acid ameliorates hyperglycemia and insulin sensitivity in diabetic rats, potentially by modulating the expression of PEPCK and GLUT4Drug Design, Development and Therapy, 2016
- Aging as a Precipitating Factor in Chronic Restraint Stress-Induced Tau Aggregation Pathology, and the Protective Effects of Rosmarinic AcidJournal of Alzheimer’s Disease, 2015
- Updates on Aldose Reductase Inhibitors for Management of Diabetic Complications and Non-diabetic DiseasesMini-Reviews in Medicinal Chemistry, 2015
- The Cellular Protective Effects of Rosmarinic Acid: From Bench to BedsideCurrent Neurovascular Research, 2015
- Kidney Proximal Tubular Epithelial-Specific Overexpression of Netrin-1 Suppresses Inflammation and Albuminuria through Suppression of COX-2-Mediated PGE2 Production in Streptozotocin-Induced Diabetic MiceThe American Journal of Pathology, 2012
- Molecular mechanisms linking diabetes mellitus and Alzheimer disease: beta-amyloidpeptide, insulin signaling, and neuronal functionMolecular BioSystems, 2011
- Aldose Reductase / Polyol Inhibitors for Diabetic RetinopathyCurrent Pharmaceutical Biotechnology, 2011
- Biochemical Pathways for Microvascular Complications of Diabetes MellitusAnnals of Pharmacotherapy, 2003